Technical analysis of Cellectis stocks shows it could experience a bullish trend in the short-term before it fades into a bearish longer-term trend. Cellectis SA is a biotech firm that mainly focuses on creating immunotherapies from the CAR-T gene edited cells. The company’s main goal is to create a new generation of cancer therapies from …
Cellectis stocks on Short-Term Bull reversing soon Read More »
The search for the fountain of youth is never-ending. In an interview with CNN Money’s Martina Fuchs, David Sinclair, a leading scientist on longevity from the Department of Genetics at Harvard School clarified the question on anti aging medicine. Proof-Of-Concept Of The Anti-Aging Medicine According to Sinclair, about 30% of his colleagues at work use …
Anti Aging Medicine | Scientist On Longevity Clarifies Read More »
Genome modification may be the answer for William Parenteau, a Pediatric Surgeon, whom parents usually call after noticing some abnormalities with an unborn child following a prenatal genetic test. William works at the Philadelphia Children’s Hospital, and he can only fix these abnormalities after the unborn children leave their mother’s womb, but this might be …
Genome Modification In The Womb About To Materialize Read More »
Gene hacking has always piqued the interest of Keoni Gandall. He was a teenager when he started performing cutting-edge research and gene hacking in his bedroom laboratory in Huntington Beach, California. Instead of buying video games as his friends do, he acquired a transilluminator, a centrifuge, and two thermocyclers, and pursue his hobby of cloning …
